Status:
COMPLETED
Botox Cosmetic and the Young Patient With Glabellar Furrows
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
Allergan
Conditions:
Glabellar Furrows
Eligibility:
FEMALE
30-50 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to see if consistent treatment with Botox will lead to longer lasting effects. Botox is an injectable liquid that is approved by the U.S. Food and Drug Administration to r...
Eligibility Criteria
Inclusion
- Female
- Fitzpatrick Skin Types I-III
- Between 30 and 50 years of age
- At least moderate severity at maximum frown
Exclusion
- Prior botulinum toxin treatment
- Any disorder (such as myasthenia gravis, Eaton-Lambert syndrome) or agent (such as aminoglycoside antibiotics) that might interfere with neuromuscular function
- Any other condition or situation that might put the subject at significant risk, confound the study results (such as significant pre-existing brow or eyelid ptosis)
- Allergy or sensitivity to any study component
- Participation in another clinical study within 30 days of the study start date
- Are planning other facial cosmetic procedures during the study period, or are pregnant, breastfeeding, or planning a pregnancy during the study.
Key Trial Info
Start Date :
February 8 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00856999
Start Date
February 8 2005
End Date
November 17 2010
Last Update
July 23 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.